Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

Early substrate-based radiofrequency catheter ablation (RFCA) was associated with reduced risk of implantable cardioverter defibrillator (ICD) therapies, but with no meaningful difference ...

Silent heart attacks in women why clear arteries don’t guarantee safety Read ahead to know about MINOCA subtle symptoms and ...

Over the past six decades, anti-thrombotic drug therapies have undergone a revolution, leading to major improvements in ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

A new microneedle patch delivers IL-4 directly into damaged heart tissue, helping the heart rebuild after a heart attack. The treatment encourages immune cells to switch into a healing mode while ...

Heart attack, a sudden blockage of blood flow to the heart muscle, differs from chronic cardiac failure, where the heart ...

The original paper, ‘CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction,’ can be found here: ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

Annual Meeting, GE HealthCare will showcase a wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care. For more than a ...

Tonmya (cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals.

New findings show that almost half of future first-time heart-attack patients would not be flagged by existing tools, raising ...